X4 Pharmaceuticals, Inc reports

Company location: Boston, MA
Fiscal year end: 31 December

X4 Pharmaceuticals, Inc has filed 808 SEC EDGAR filings since 24 Sep 2010

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 351-375 of 808 matching filings.

Per page

25

Current page

15

8-K File 001-38295

8-K

Filing date: 29 Jul 2022
Reporting date: 25 Jul 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

424B3 File 333-264459

424B3

Filing date: 29 Jul 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D File 005-90199

GROWTH EQUITY OPPORTUNITIES 18 VGE, LLC / X4 PHARMACEUTICALS, INC. -- SCHEDULE 1

Filing date: 19 Jul 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

D File 021-452949

D filing

Filing date: 19 Jul 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 01 Jul 2022
Reporting date: 30 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 01 Jul 2022
Reporting date: 30 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-38295

8-K

Filing date: 01 Jul 2022
Reporting date: 30 Jun 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4

Filing date: 27 Jun 2022
Reporting date: 06 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 27 Jun 2022
Reporting date: 06 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 27 Jun 2022
Reporting date: 06 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 27 Jun 2022
Reporting date: 06 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 27 Jun 2022
Reporting date: 06 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 27 Jun 2022
Reporting date: 06 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 27 Jun 2022
Reporting date: 24 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 27 Jun 2022
Reporting date: 06 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 27 Jun 2022
Reporting date: 24 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 27 Jun 2022
Reporting date: 24 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 27 Jun 2022
Reporting date: 24 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 17 Jun 2022
Reporting date: 16 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 17 Jun 2022
Reporting date: 16 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 17 Jun 2022
Reporting date: 16 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 17 Jun 2022
Reporting date: 16 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-38295

8-K

Filing date: 07 Jun 2022
Reporting date: 06 Jun 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4

Filing date: 06 Jun 2022
Reporting date: 03 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-38295

8-K

Filing date: 20 May 2022
Reporting date: 20 May 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .